Bausch Health Companies (BHC) Change in Accured Expenses (2009 - 2026)

Bausch Health Companies has disclosed Change in Accured Expenses across 18 years of filings, most recently posting -$150.0 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$150.0 million, down 51.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$127.0 million (down 161.35% YoY), and the FY2025 annual result was -$76.0 million, down 121.29% from the prior year.
• Change in Accured Expenses came in at -$150.0 million for Q1 2026 at Bausch Health Companies, up from -$284.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $166.0 million in Q3 2023 to a low of -$284.0 million in Q4 2025.
• The 5-year median for Change in Accured Expenses is $47.0 million (2022), against an average of $12.6 million.
• Across the five-year window, Change in Accured Expenses surged 737.5% in 2024 and sank 1283.33% in 2025, its largest moves.
• Bausch Health Companies' Change in Accured Expenses stood at $47.0 million in 2022, then surged by 106.38% to $97.0 million in 2023, then sank by 75.26% to $24.0 million in 2024, then tumbled by 1283.33% to -$284.0 million in 2025, then jumped by 47.18% to -$150.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$150.0 million (Q1 2026), -$284.0 million (Q4 2025), and $144.0 million (Q3 2025), per Business Quant data.